PGENPRECIGEN, INC.

Nasdaq precigen.com


$ 1.29 $ -0.04 (-3.01 %)    

Thursday, 09-May-2024 15:59:53 EDT
QQQ $ 443.74 $ 0.84 (0.19 %)
DIA $ 395.64 $ 0.58 (0.15 %)
SPY $ 522.41 $ 0.89 (0.17 %)
TLT $ 90.28 $ 0.01 (0.01 %)
GLD $ 218.88 $ -0.92 (-0.42 %)
$ 1.29
$ 1.30
$ 0.00 x 0
$ 1.29 x 100
$ 1.28 - $ 1.32
$ 0.84 - $ 1.88
746,366
na
315.45M
$ 1.02
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-19-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-10-2023 03-31-2023 10-Q
5 03-06-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-09-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-08-2021 09-30-2021 10-Q
11 08-09-2021 06-30-2021 10-Q
12 05-10-2021 03-31-2021 10-Q
13 03-01-2021 12-31-2020 10-K
14 11-09-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-02-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-09-2019 06-30-2019 10-Q
20 05-09-2019 03-31-2019 10-Q
21 03-01-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 08-13-2018 06-30-2018 10-Q
24 05-10-2018 03-31-2018 10-Q
25 03-01-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-09-2017 06-30-2017 10-Q
28 05-10-2017 03-31-2017 10-Q
29 03-01-2017 12-31-2016 10-K
30 11-09-2016 09-30-2016 10-Q
31 08-09-2016 06-30-2016 10-Q
32 05-10-2016 03-31-2016 10-Q
33 02-29-2016 12-31-2015 10-K
34 11-09-2015 09-30-2015 10-Q
35 08-10-2015 06-30-2015 10-Q
36 05-11-2015 03-31-2015 10-Q
37 03-02-2015 12-31-2014 10-K
38 11-13-2014 09-30-2014 10-Q
39 08-14-2014 06-30-2014 10-Q
40 05-09-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 precigen-to-present-late-breaking-abstract-for-pivotal-phase-2-study-data-for-prgn-2012-adenoverse-immunotherapy-for-the-treatment-of-patients-with-recurrent-respiratory-papillomatosis-at-the-2024-asco-annual-meeting

Precigen, Inc. (NASDAQ:PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies...

 jp-morgan-downgrades-precigen-to-underweight

JP Morgan analyst Brian Cheng downgrades Precigen (NASDAQ:PGEN) from Neutral to Underweight.

 why-factset-research-shares-are-trading-lower-by-around-5-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-th...

 jmp-securities-reiterates-market-outperform-on-precigen-maintains-14-price-target

JMP Securities analyst Jason Butler reiterates Precigen (NASDAQ:PGEN) with a Market Outperform and maintains $14 price target.

 hc-wainwright--co-reiterates-buy-on-precigen-maintains-6-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Precigen (NASDAQ:PGEN) with a Buy and maintains $6 price t...

 recap-precigen-q4-earnings
Recap: Precigen Q4 Earnings
03/19/2024 20:25:06

 precigen-gives-business-updates-significant-progress-made-in-the-development-of-the-prgn-2012--adenoverse-immunotherapy-for-the-treatment-of-rrp-plans-to-submit-a-bla-under-an-accelerated-approval-pathway-in-2h-of-2024

–   Significant progress made in the development of the PRGN-2012 AdenoVerse immunotherapy for the treatment of RRP; Precigen p...

 precigen-eps-039-vs-040-yoy-cash-cash-equivalents-short-term-and-long-term-investments-totaled-629m-as-of-december-31-2023

Full Year 2023 Financial Results Compared to Prior Year PeriodResearch and development expenses increased $1.4 million, or 3.1%...

 earnings-scheduled-for-march-19-2024

Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per...

 preview-precigens-earnings
Preview: Precigen's Earnings
03/18/2024 14:00:59

 mondaycom-reports-q4-results-joins-an2-therapeuticsand-other-big-stocks-moving-lower-in-mondays-pre-market-session

U.S. stock futures were mixed this morning, with the Dow futures trading lower by around 45 points on Monday. Shares of monda...

 why-amtech-systems-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) rose sharply in today’s pre-market trading after the company reported upbeat res...

 why-longboard-pharmaceuticals-shares-are-trading-higher-by-around-200-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Longboard Pharmaceuticals, Inc.

 precigen-sponsored-study-randomized-open-label-two-arm-phase-2-study-to-evaluate-efficacy-and-safety-of-prgn-2009-in-combination-with-pembrolizumab-versus-pembrolizumab-in-patients-with-recurrent-or-metastatic-cervical-cancer-update-1252023-not-yet-recruiting

https://clinicaltrials.gov/study/NCT06157151

 why-wynn-resorts-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results.

 why-td-synnex-shares-are-trading-lower-by-over-5-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results...

 fisker-intercept-pharmaceuticals-immunovant-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in ...

 why-nordstrom-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers Alset Capital Acquisition Corp. (NASDAQ: ACAX) shares climbed 66.2% to $12.93.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION